Gene · 369
Papers2,279
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 2,279
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PD-L1 promotes tumor growth and progression by activating WIP and β-catenin signaling pathways and predicts poor prognosis in lung cancer. | Cell Death Dis | 2020 | 32632098 | PubTator, text mining | PubMed |
| Heterogenous Nuclear Ribonucleoprotein H1 Promotes Colorectal Cancer Progression through the Stabilization of mRNA of Sphingosine-1-Phosphate Lyase 1. | Int J Mol Sci | 2020 | 32630435 | PubTator, text mining | PubMed |
| Insights into Aflatoxin B1 Toxicity in Cattle: An In Vitro Whole-Transcriptomic Approach. | Toxins (Basel) | 2020 | 32610656 | PubTator, text mining | PubMed |
| Targeted Therapy in Melanoma and Mechanisms of Resistance. | Int J Mol Sci | 2020 | 32605090 | PubTator, text mining | PubMed |
| Integration of Tumor Mutation Burden and PD-L1 Testing in Routine Laboratory Diagnostics in Non-Small Cell Lung Cancer. | Cancers (Basel) | 2020 | 32599951 | PubTator, text mining | PubMed |
| Allosteric pluripotency as revealed by protein kinase A. | Sci Adv | 2020 | 32596469 | PubTator, text mining | PubMed |
| Bone mesenchymal stem cells are recruited via CXCL8-CXCR2 and promote EMT through TGF-β signal pathways in oral squamous carcinoma. | Cell Prolif | 2020 | 32588946 | PubTator, text mining | PubMed |
| Development of a cell-free split-luciferase biochemical assay as a tool for screening for inhibitors of challenging protein-protein interaction targets. | Wellcome Open Res | 2020 | 32587898 | PubTator, text mining | PubMed |
| Mouse brain transcriptome responses to inhaled nanoparticulate matter differed by sex and APOE in Nrf2-Nfkb interactions. | Elife | 2020 | 32579111 | PubTator, text mining | PubMed |
| Targeting KRAS Mutant Non-Small-Cell Lung Cancer: Past, Present and Future. | Int J Mol Sci | 2020 | 32560574 | PubTator, text mining | PubMed |
| Mucinous borderline ovarian tumors with BRAFV600E mutation may have low risk for progression to invasive carcinomas. | Arch Gynecol Obstet | 2020 | 32556513 | PubTator, text mining | PubMed |
| Low-Dose Vertical Inhibition of the RAF-MEK-ERK Cascade Causes Apoptotic Death of KRAS Mutant Cancers. | Cell Rep | 2020 | 32553168 | PubTator, text mining | PubMed |
| Hypoxia-induced alternative splicing: the 11th Hallmark of Cancer. | J Exp Clin Cancer Res | 2020 | 32536347 | PubTator, text mining | PubMed |
| Generation of myogenic progenitor cell-derived smooth muscle cells for sphincter regeneration. | Stem Cell Res Ther | 2020 | 32532320 | PubTator, text mining | PubMed |
| Efficient blockade of locally reciprocated tumor-macrophage signaling using a TAM-avid nanotherapy. | Sci Adv | 2020 | 32494745 | PubTator, text mining | PubMed |
| Multiple subcutaneous juvenile xanthogranulomas with a blue hue in a neonate: An atypical presentation. | JAAD Case Rep | 2020 | 32490115 | PubTator, text mining | PubMed |
| Melanoma with in-frame deletion of MAP2K1: a distinct molecular subtype of cutaneous melanoma mutually exclusive from BRAF, NRAS, and NF1 mutations. | Mod Pathol | 2020 | 32483240 | PubTator, text mining | PubMed |
| Hallmarks of Splicing Defects in Cancer: Clinical Applications in the Era of Personalized Medicine. | Cancers (Basel) | 2020 | 32481522 | PubTator, text mining | PubMed |
| BRAF mutation and its inhibitors in sarcoma treatment. | Cancer Med | 2020 | 32476297 | PubTator, text mining | PubMed |
| Encorafenib, Binimetinib, and Cetuximab in BRAF V600E-Mutated Colorectal Cancer. | Transl Oncol | 2020 | 32470910 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/369/papers?page=48